JP2012527877A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527877A5
JP2012527877A5 JP2012512354A JP2012512354A JP2012527877A5 JP 2012527877 A5 JP2012527877 A5 JP 2012527877A5 JP 2012512354 A JP2012512354 A JP 2012512354A JP 2012512354 A JP2012512354 A JP 2012512354A JP 2012527877 A5 JP2012527877 A5 JP 2012527877A5
Authority
JP
Japan
Prior art keywords
antigen
binding
binding protein
epitope
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012512354A
Other languages
English (en)
Japanese (ja)
Other versions
JP5901517B2 (ja
JP2012527877A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/057231 external-priority patent/WO2010136483A2/en
Publication of JP2012527877A publication Critical patent/JP2012527877A/ja
Publication of JP2012527877A5 publication Critical patent/JP2012527877A5/ja
Application granted granted Critical
Publication of JP5901517B2 publication Critical patent/JP5901517B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012512354A 2009-05-28 2010-05-26 抗原結合性タンパク質 Expired - Fee Related JP5901517B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18189309P 2009-05-28 2009-05-28
US61/181,893 2009-05-28
PCT/EP2010/057231 WO2010136483A2 (en) 2009-05-28 2010-05-26 Antigen-binding proteins

Publications (3)

Publication Number Publication Date
JP2012527877A JP2012527877A (ja) 2012-11-12
JP2012527877A5 true JP2012527877A5 (https=) 2013-07-11
JP5901517B2 JP5901517B2 (ja) 2016-04-13

Family

ID=42671768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012512354A Expired - Fee Related JP5901517B2 (ja) 2009-05-28 2010-05-26 抗原結合性タンパク質

Country Status (6)

Country Link
US (1) US9394374B2 (https=)
EP (1) EP2435482B1 (https=)
JP (1) JP5901517B2 (https=)
CA (1) CA2763491A1 (https=)
ES (1) ES2729422T3 (https=)
WO (1) WO2010136483A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
NZ629682A (en) * 2013-03-15 2017-03-31 Omeros Corp Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same
CN105849124B (zh) * 2013-12-20 2022-04-12 豪夫迈·罗氏有限公司 双重特异性抗体
AR104368A1 (es) 2015-04-03 2017-07-19 Lilly Co Eli Anticuerpos biespecíficos anti-cd20- / anti-baff
JP6871948B2 (ja) 2016-04-27 2021-05-19 アッヴィ・インコーポレイテッド 抗il−13抗体を使用する、il−13活性が有害である疾患の治療方法
WO2018083087A2 (en) 2016-11-02 2018-05-11 Glaxosmithkline Intellectual Property (No.2) Limited Binding proteins
CN106645352B (zh) * 2017-01-22 2019-01-18 浙江省医学科学院 一种用于检测血吸虫的纳米抗体组合物、免疫传感器及其制备方法和应用
CN109942706A (zh) * 2017-12-21 2019-06-28 三生国健药业(上海)股份有限公司 结合人il-5的单克隆抗体、其制备方法和用途
CN113710229B (zh) 2019-02-25 2026-01-06 芝加哥大学 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
CN113307870B (zh) * 2020-10-30 2022-12-23 上海洛启生物医药技术有限公司 抗il5纳米抗体及其应用
CN118401551A (zh) * 2022-04-15 2024-07-26 上海韦青医药科技咨询有限公司 用于治疗皮肤及粘膜炎症的抗体及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006323412A1 (en) * 2005-12-06 2007-06-14 Domantis Limited Ligands that have binding specificity for EGFR and/or VEGF and methods of use therefor
US20100047171A1 (en) * 2006-01-24 2010-02-25 Roland Beckmann Fusion Proteins That Contain Natural Junctions
EP2441838A3 (en) * 2006-01-24 2013-07-10 Domantis Limited Fusion proteins that contain natural junctions
EP2535349A1 (en) * 2007-09-26 2012-12-19 UCB Pharma S.A. Dual specificity antibody fusions
US20090148905A1 (en) 2007-11-30 2009-06-11 Claire Ashman Antigen-binding constructs

Similar Documents

Publication Publication Date Title
JP2012527877A5 (https=)
IN2012DN02535A (https=)
JP2018537415A5 (https=)
JP2012518425A5 (https=)
WO2021244089A1 (zh) 新型冠状病毒(sars-cov-2)刺突蛋白结合分子及其应用
JP2021525530A5 (https=)
JP2020521751A5 (https=)
JP2019514361A5 (https=)
JP2020524510A5 (https=)
RU2015100656A (ru) Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
JP2012527875A5 (https=)
JP2017529067A5 (https=)
AR077088A1 (es) Proteinas biespecificas de union a antigeno
JP2010511397A5 (https=)
JP2010539921A5 (https=)
JP2016519124A5 (https=)
JP2013541335A5 (https=)
HRP20191219T1 (hr) Molekule protutijela koje imaju specifičnost za ljudski ox40
RU2012143793A (ru) Биспецифические двухвалентные антитела анти-vegf/анти-ang-2
JP2013538555A5 (https=)
HRP20201191T1 (hr) Mutirani multispecifični fab fragmenti antitijela
JP2018530331A5 (https=)
JP2013121353A5 (https=)
JP2013519364A5 (https=)
HRP20171608T1 (hr) Protutijela koja vežu albumin i njihovi vezujući fragmenti